Overture Life

📍 Palo Alto, United States🗓 Founded 2017👥 41 employees💰 Last funded Feb 2024
Biotechnology Research🌐 overture.life
Website LinkedIn
Overture Life is a clinical-stage biotechnology company whose mission is to automate assisted reproductive processes to improve IVF pregnancy outcomes through process automation and non-invasive embryo selection. Its revolutionary technologies help standardize fertility treatments, by simplifying techniques and optimizing resources to make reproductive technologies more affordable, reliable, and accessible. Founded by recognized global leaders in embryo genetic testing and assisted reproduction, Overture is backed by Khosla Ventures, Felicis Ventures, Octopus Ventures and GV, and maintains offices in the U.S. and Spain.
3
Total investors
1
Early stage
0
Mid stage
2
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity2019–2024 · investors recorded per year
201912023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Overture Life?
Overture Life has 3 investors on record on gritt.io, including 1 early-stage backers and 2 late-stage investors.
When did Overture Life last raise funding?
The most recent investment in Overture Life recorded on gritt.io was in February 2024.
When was Overture Life founded?
Overture Life was founded in 2017.
What industry is Overture Life in?
Overture Life operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Overture Life based?
Overture Life is headquartered in Palo Alto, United States.